Skip to main
ALAB

ALAB Stock Forecast & Price Target

ALAB Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 39%
Buy 39%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

Astera Labs Inc. has demonstrated significant revenue growth and strong gross margins, which have effectively offset increasing operating expenses, showcasing its robust financial health. The company anticipated quarterly revenue guidance of $249.0 million, reflecting an 8.0% quarter-over-quarter increase and a remarkable 76.5% year-over-year growth, exceeding both internal and market estimates. Additionally, the increasing demand for its PCIe Gen 6 products, which contributed over 20% of total revenue in the latest quarter, highlights the company's strategic positioning in the rapidly growing semiconductor sector, particularly in AI-driven infrastructure.

Bears say

Astera Labs Inc's revenue growth heavily relies on the momentum of data center infrastructure spending, which poses a risk during periods of macroeconomic slowdowns that could lead to reduced capital investment. The company's exposure to fluctuations in this sector may negatively impact its financial performance, hindering its ability to meet growth expectations. Additionally, the reliance on a concentrated revenue stream from the United States further amplifies vulnerability to regional economic shifts, raising concerns about long-term sustainability.

ALAB has been analyzed by 18 analysts, with a consensus rating of Buy. 39% of analysts recommend a Strong Buy, 39% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Astera Labs Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Astera Labs Inc (ALAB) Forecast

Analysts have given ALAB a Buy based on their latest research and market trends.

According to 18 analysts, ALAB has a Buy consensus rating as of Apr 27, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $196.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $196.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Astera Labs Inc (ALAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.